These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25819276)

  • 1. Modifications of natural peptides for nanoparticle and drug design.
    Jallouk AP; Palekar RU; Pan H; Schlesinger PH; Wickline SA
    Adv Protein Chem Struct Biol; 2015; 98():57-91. PubMed ID: 25819276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxin bioportides: exploring toxin biological activity and multifunctionality.
    Kerkis I; de Brandão Prieto da Silva AR; Pompeia C; Tytgat J; de Sá Junior PL
    Cell Mol Life Sci; 2017 Feb; 74(4):647-661. PubMed ID: 27554773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of endosomolytic reagents by branching of cell-penetrating peptides: tools for the delivery of bioactive compounds to live cells in cis or trans.
    Angeles-Boza AM; Erazo-Oliveras A; Lee YJ; Pellois JP
    Bioconjug Chem; 2010 Dec; 21(12):2164-7. PubMed ID: 21043514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural polymorphism of non-covalent peptide-based delivery systems: highway to cellular uptake.
    Deshayes S; Konate K; Aldrian G; Crombez L; Heitz F; Divita G
    Biochim Biophys Acta; 2010 Dec; 1798(12):2304-14. PubMed ID: 20541523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane-active peptides from marine organisms--antimicrobials, cell-penetrating peptides and peptide toxins: applications and prospects.
    Ponnappan N; Budagavi DP; Yadav BK; Chugh A
    Probiotics Antimicrob Proteins; 2015 Mar; 7(1):75-89. PubMed ID: 25559972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing and enhancing the antifungal activity of corneal specific cell penetrating peptide using gelatin hydrogel delivery system.
    Amit C; Muralikumar S; Janaki S; Lakshmipathy M; Therese KL; Umashankar V; Padmanabhan P; Narayanan J
    Int J Nanomedicine; 2019; 14():605-622. PubMed ID: 30697045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy.
    Guo F; Fu Q; Zhou K; Jin C; Wu W; Ji X; Yan Q; Yang Q; Wu D; Li A; Yang G
    J Nanobiotechnology; 2020 Mar; 18(1):48. PubMed ID: 32183823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Primary Mechanism of Cellular Internalization for a Short Cell- Penetrating Peptide as a Nano-Scale Delivery System.
    Liu BR; Huang YW; Korivi M; Lo S-Y; Aronstam RS; Lee H-J
    Curr Pharm Biotechnol; 2017; 18(7):569-584. PubMed ID: 28828981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-penetrating peptides: achievements and challenges in application for cancer treatment.
    Shin MC; Zhang J; Min KA; Lee K; Byun Y; David AE; He H; Yang VC
    J Biomed Mater Res A; 2014 Feb; 102(2):575-87. PubMed ID: 23852939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
    Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
    Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides and Antibiotic Therapy: Advances in Design and Delivery.
    Schafer ME; Browne H; Goldberg JB; Greenberg DE
    Acc Chem Res; 2021 May; 54(10):2377-2385. PubMed ID: 33881843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases.
    Pirhaghi M; Mamashli F; Moosavi-Movahedi F; Arghavani P; Amiri A; Davaeil B; Mohammad-Zaheri M; Mousavi-Jarrahi Z; Sharma D; Langel Ü; Otzen DE; Saboury AA
    Mol Pharm; 2024 May; 21(5):2097-2117. PubMed ID: 38440998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer targeting peptides.
    Kalmouni M; Al-Hosani S; Magzoub M
    Cell Mol Life Sci; 2019 Jun; 76(11):2171-2183. PubMed ID: 30877335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-Inspired Technologies for Peptide Delivery.
    Covarrubias-Zambrano O; Yu J; Bossmann SH
    Curr Protein Pept Sci; 2020; 21(4):379-400. PubMed ID: 31793426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empowering the Potential of Cell-Penetrating Peptides for Targeted Intracellular Delivery via Molecular Self-Assembly.
    Shi Y; Conde J; Azevedo HS
    Adv Exp Med Biol; 2017; 1030():265-278. PubMed ID: 29081058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retro-inverso cell-penetrating peptide for siRNA delivery.
    Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
    J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating peptides: design, synthesis, and applications.
    Copolovici DM; Langel K; Eriste E; Langel Ü
    ACS Nano; 2014 Mar; 8(3):1972-94. PubMed ID: 24559246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell penetrating peptides: A concise review with emphasis on biomedical applications.
    Derakhshankhah H; Jafari S
    Biomed Pharmacother; 2018 Dec; 108():1090-1096. PubMed ID: 30372809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.